SEC Company Response from ROCKET PHARMACEUTICALS, INC. (RCKT, RCKTW) (CIK 0001281895) (RCKT) — Feb 3, 2015
ROCKET PHARMACEUTICALS, INC. (RCKT, RCKTW) (CIK 0001281895)
Date: Feb. 3, 2015 · CIK: 0001281895 · Accession: 0001193125-15-032074
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-199859
Letter
VIA EDGAR
February 3, 2015
United State Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 4720
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jeffrey P. Riedler
Austin Stephenson
Re: Inotek Pharmaceuticals Corporation (the “Company”)
Registration Statement on Form S-1 File No. 333-199859
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), and as representatives of the several underwriters of the Company’s proposed public offering of shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”) and proposed offering of the Company’s convertible senior notes due 2020 (the “Convertible Notes”), we hereby join the Company’s request for acceleration of the effective date of the above-referenced Registration Statement, as amended, requesting effectiveness for 4:00 p.m. (ET) on February 5, 2015, or as soon thereafter as practicable.
Pursuant to Rule 460 of the Act, we wish to advise you that we have distributed approximately 1,400 copies of the Company’s preliminary prospectus relating to the Common Stock, dated January 21, 2015, and approximately 1,075 copies of the Company’s preliminary prospectus relating to the Convertible Notes, dated January 21, 2015, through the date hereof to underwriters, dealers, institutions and others.
The undersigned, as representatives of the several underwriters, have complied and will continue to comply, and have been informed by the participating underwriters that they have complied and will continue to comply, with the provisions of Rule 15c2-8 of the Securities Exchange Act of 1934, as amended.
[Signature page follows]
Very truly yours,
COWEN AND COMPANY, LLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP VIA EDGAR February 3, 2015 United State Securities and Exchange Commission Division of Corporation Finance Mail Stop 4720 100 F Street, N.E. Washington, D.C. 20549 Attn: Jeffrey P. Riedler Austin Stephenson Re: Inotek Pharmaceuticals Corporation (the “Company”) Registration Statement on Form S-1 File No. 333-199859 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), and as representatives of the several underwriters of the Company’s proposed public offering of shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”) and proposed offering of the Company’s convertible senior notes due 2020 (the “Convertible Notes”), we hereby join the Company’s request for acceleration of the effective date of the above-referenced Registration Statement, as amended, requesting effectiveness for 4:00 p.m. (ET) on February 5, 2015, or as soon thereafter as practicable. Pursuant to Rule 460 of the Act, we wish to advise you that we have distributed approximately 1,400 copies of the Company’s preliminary prospectus relating to the Common Stock, dated January 21, 2015, and approximately 1,075 copies of the Company’s preliminary prospectus relating to the Convertible Notes, dated January 21, 2015, through the date hereof to underwriters, dealers, institutions and others. The undersigned, as representatives of the several underwriters, have complied and will continue to comply, and have been informed by the participating underwriters that they have complied and will continue to comply, with the provisions of Rule 15c2-8 of the Securities Exchange Act of 1934, as amended. [Signature page follows] Very truly yours, COWEN AND COMPANY, LLC PIPER JAFFRAY & CO. NOMURA SECURITIES INTERNATIONAL, INC. Acting on their own behalf and as representatives of several underwriters BY: COWEN AND COMPANY, LLC By: /s/ Grant Miller Name: Grant Miller Title: Managing Director BY: PIPER JAFFRAY & CO. By: /s/ Christie L. Christina Name: Christie L. Christina Title: Managing Director By: NOMURA SECURITIES INTERNATIONAL, INC. By: /s/ Arun Master Name: Arun Master Title: Managing Director